Description
Vutrisiran is an investigational, liver-directed small interfering ribonucleic acid (siRNA) compound designed for research on transthyretin (TTR)-mediated amyloidosis.
Solubility
< 1 mg/mL refers to the product slightly soluble or insoluble
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 2 years
PreparationUse
polyneuropathy treatment